Behavioral science is being applied in unique ways for enterprise-imaging product design. #webinar
Sponsored Content | Webinar | Enterprise Imaging
WEBINAR: How to Transform Imaging with Behavioral Science — Now Available On Demand

Behavioral science is being applied in unique ways for enterprise-imaging product design. Behavioral science is the ...

Home January 19, 2023
Home
Grants will provide increased opportunity for clinical research within interventional cardiology and address disparities in care
News | SCAI
SCAI Announces Recipients of Early Career Research Grants

January 18, 2023 — the Society for Cardiovascular Angiography & Interventions (SCAI) announced four recipients of their ...

Home January 18, 2023
Home
Phone calls from a nurse may improve survival for patients treated for heart failure, according to a new study by investigators from the Smidt Heart Institute at Cedars-Sinai.
News | Heart Failure
Calling Patients After Heart Failure May Save Lives

January 18, 2023 — Phone calls from a nurse may improve survival for patients treated for heart failure, according to a ...

Home January 18, 2023
Home
According to the U.S. Centers for Disease Control and Prevention (CDC), one person dies every 37 seconds in the United States from cardiovascular disease.
Feature | Computed Tomography (CT) | By Christine Book
Rising Demand for Cardiac CT Positions Market for Major Growth

According to the U.S. Centers for Disease Control and Prevention (CDC), one person dies every 37 seconds in the United ...

Home January 18, 2023
Home
The risk of hypertension increases significantly with orthostatic circulatory disorders.
News | Hypertension
RUDN University Doctors Tested a Novel Approach to Detecting Future Arterial Hypertension in Healthy People

January 17, 2023 — Arterial hypertension(AH), or high blood pressure, can be prevented if diagnosed pre-clinically on ...

Home January 17, 2023
Home
RUDN doctors analyzed the latest research on the use of RNA for the treatment and diagnosis of ischemic stroke. And, although it is too early to talk about clinical use, one of the RNAs turned out to be both a promising biomarker and a therapeutic target
News | Stroke
RNA Will Help Treat and Diagnose Ischemic Stroke

January 17, 2023 — Ischemic stroke, or cerebral infarction, ranks first in prevalence among diseases that lead to death ...

Home January 17, 2023
Home
Brian Jensen
News | Heart Failure
Getting to the Heart of Chemotherapeutic Cardiotoxicity

January 16, 2023 — On any given Tuesday, you will find Brian C. Jensen, MD, cardiologist and physician-scientist ...

Home January 16, 2023
Home
Medical center signs agreement to acquire the Company’s digital signal processing technology for arrhythmia care
News | EP Device Monitoring Systems
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP Technology

January 13, 2023 — BioSig Technologies, Inc., an advanced digital signal processing technology company delivering ...

Home January 13, 2023
Home
ASNC releases comprehensive tool for assessing quality, setting meaningful goals, improving patient care in SPECT MPI laboratories
News | Cardiac Imaging
New Guide Will Change How Cardiac Imagers Approach Quality Improvement

January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most ...

Home January 13, 2023
Home
Patients seen at transplant centers had almost 80% higher odds to receive “bridge-to-transplant” designation
News | Heart Failure
Medicare Policy Change Could Increase Inequity in Heart Transplant Access, Study Finds

January 13, 2023 — A change to Medicare policy surrounding heart transplant may lead to increased inequities in access ...

Home January 13, 2023
Home
SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
News | Drug-Eluting Balloons
MedAlliance Selution SLR is the First DEB to Receive Coronary de novo IDE Approval, its Fourth FDA IDE DEB Approval

January 12, 2023 — Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA ...

Home January 12, 2023
Home
ADVANCE Trial compares sac regression in the Medtronic Endurant II/IIs stent graft system and the Gore® Excluder AAA Device Family systems
News | Stent Grafts
Medtronic Announces First Enrollment in Head-to-head Global Randomized Trial Evaluating Durability of Endovascular Aneurysm Repair

January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...

Home January 12, 2023
Home
Alameda, CA-based global healthcare company Penumbra has announced Food & Drug Administration (FDA) clearance and launch of Lightning Flash, which the company reports is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus.
News | Cardiovascular Business
FDA Clearance and Launch Granted to Penumbra Mechanical Thrombectomy System

January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...

Home January 11, 2023
Home
Phase 2 trials underway with ninerafaxstat in three cardiovascular indications; multiple data read-outs expected in 2023
News | Cardiovascular Clinical Studies
Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction

January 11, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies ...

Home January 11, 2023
Home
Dean Kereiakes, MD, MSCAI
News | Embolic Protection Devices
Shockwave Intravascular Lithotripsy-assisted TMVR Shows Promise for Patients with Severe Stenosis and Regurgitation

January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...

Home January 11, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now